Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
This grant funds innovative research in hematology to stimulate new investigations and advancements in the field.
About this program
The Stimulating Hematology Investigation: New Endeavors (SHINE) grant is designed to support groundbreaking research projects in the area of hematology. It aims to encourage researchers to explore new ideas and methodologies that can lead to significant advancements in understanding blood disorders and treatments. This grant is particularly focused on fostering innovative approaches that may not fit traditional research paradigms. Researchers in the field of hematology, including those from academic institutions, nonprofit organizations, and other research entities, are encouraged to apply. The SHINE grant is intended for projects that can demonstrate potential for high impact in the field of hematology. Eligible applicants include academic researchers, institutions, and organizations that are actively engaged in hematology research. The grant is not intended for clinical trials, as specified by the R01 Clinical Trial Not Allowed designation. The funding will support various aspects of research, including preliminary studies, data collection, and analysis, with the goal of advancing knowledge and treatment options in hematology. Successful applicants will be expected to demonstrate a clear plan for their research and its potential implications for the field.
Eligibility
Researchers and institutions engaged in hematology research, excluding clinical trials.